A

Achieve Life Sciences
D

ACHV

2.68500
USD
-0.01
(-0.37%)
قبل الجلسة
حجم التداول
344
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
133,404,418
أصول ذات صلة
A
APVO
-0.18000
(-5.56%)
3.06000 USD
C
CRVS
-0.05500
(-1.16%)
4.70000 USD
C
CYCN
-0.01000
(-0.33%)
2.98000 USD
L
LPTX
-0.00700
(-1.93%)
0.35500 USD
O
OCUL
0.290
(2.43%)
12.210 USD
O
OGEN
-0.06000
(-4.26%)
1.35000 USD
المزيد
الأخبار المقالات

العنوان: Achieve Life Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.